Literature DB >> 20826744

Normoalbuminaemia is associated with IgA nephropathy in primary glomerulopathy with nephrotic-range proteinuria in Chinese patients.

Min Chen1, Fu-de Zhou, Ming-hui Zhao, Hai-yan Wang.   

Abstract

BACKGROUND: Massive proteinuria is often associated with hypoalbuminaemia in glomerulopathy. However, patients may have normal levels of serum albumin despite heavy proteinuria in many circumstances. This study analysed factors affecting serum levels of albumin in primary glomerulopathy patients with nephrotic-range proteinuria.
METHODS: The renal histopathological data of 780 consecutive adult patients (age ≥ 18 years old) with primary glomerulopathy and nephrotic-range proteinuria, who received native renal biopsies in Peking University First Hospital from 1998 to 2007, were retrospectively analysed.
RESULTS: Compared with patients with hypoalbuminaemia (serum albumin < 30 g/L), patients without hypoalbuminaemia were significantly younger (P < 0.001) and had significantly lower levels of proteinuria (P < 0.001). Patients without hypoalbuminaemia had a significantly higher proportion of IgA nephropathy (66.0% vs. 17.2%, P < 0.001). The independent predictors of hypoalbuminaemia in nephrotic-range proteinuria patients included age, gender, interval between onset of the disease and renal biopsy, proteinuria level, and pathological type of glomerulopathy. A serum level of albumin ≥ 35 g/L could predict IgA nephropathy with a specificity of 95.8%, and specificity increased with age.
CONCLUSIONS: Among patients with primary glomerulopathy and nephrotic-range proteinuria, normoalbuminaemia is associated with IgA nephropathy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20826744     DOI: 10.1093/ndt/gfq553

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  7 in total

1.  Venous thromboembolism in patients with membranous nephropathy.

Authors:  Sophia Lionaki; Vimal K Derebail; Susan L Hogan; Sean Barbour; Taewoo Lee; Michelle Hladunewich; Allen Greenwald; Yichun Hu; Caroline E Jennette; J Charles Jennette; Ronald J Falk; Daniel C Cattran; Patrick H Nachman; Heather N Reich
Journal:  Clin J Am Soc Nephrol       Date:  2011-11-10       Impact factor: 8.237

2.  Hypercoagulable state evaluated by thromboelastography in patients with idiopathic membranous nephropathy.

Authors:  Meng-jie Huang; Ri-bao Wei; Qing-ping Li; Xi Yang; Cui-ming Cao; Ting-yu Su; Na Wang; Rui Wang; Xiang-mei Chen
Journal:  J Thromb Thrombolysis       Date:  2016-02       Impact factor: 2.300

3.  A Rare Case of Nephrotic-Range Proteinuria in Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis.

Authors:  Rabih Nasr; Pavitra Balasubramanian; Lauren Desiderio; Mohammed Abdelattif
Journal:  Cureus       Date:  2022-05-10

4.  The difference between patients with nephrotic syndrome and nephrotic-range proteinuria in IgA nephropathy: a propensity score matched cohort study.

Authors:  Hongfen Li; Fanghao Wang; Junya Jia; Tiekun Yan; Youxia Liu; Shan Lin
Journal:  BMC Nephrol       Date:  2022-04-29       Impact factor: 2.585

5.  Malignant hypertension and nephrotic range proteinuria without hematuria: IgA nephropathy.

Authors:  R P Goswami; D Sinha; S Mondal; S Mandal; T Ete; A Nag; J Pal; A Roychowdhury; A Ghosh
Journal:  Indian J Nephrol       Date:  2013-09

6.  Clinical and pathologic characteristics of pauci-immune anti-myeloperoxidase antibody associated glomerulonephritis with nephrotic range proteinuria.

Authors:  Peng-Cheng Xu; Tong Chen; Shan Gao; Shui-Yi Hu; Li Wei; Tie-Kun Yan
Journal:  Ren Fail       Date:  2018-11       Impact factor: 2.606

7.  Elevated Microparticle Tissue Factor Activity Differentiates Patients With Venous Thromboembolism in Anti-neutrophil Cytoplasmic Autoantibody Vasculitis.

Authors:  Carmen E Mendoza; Elizabeth J Brant; Matthew L McDermott; Anne Froment; Yichun Hu; Susan L Hogan; J Charles Jennette; Ronald J Falk; Patrick H Nachman; Vimal K Derebail; Donna O'Dell Bunch
Journal:  Kidney Int Rep       Date:  2019-07-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.